-transparent.png){kind=logo}
The results of indium-111 tropolonate leucocyte scintigraphy in 105 patients with known inflammatory bowel disease are reviewed. Scintigraphy is as sensitive as radiology in detecting and assessing the extent of active colonic disease, and probably more sensitive in assessing small bowel disease. In a further 40 patients scintigraphy was successfully used as a screening test to identify, or exclude, bowel inflammation in patients with gastrointestinal symptoms. Scintigraphy has advantages over barium studies, being safe, non-invasive, more sensitive than small bowel radiology and giving additional information such as the bowel identification of intra-abdominal abscesses. The time required to label the leucocytes (about 2 hours) and the higher unit cost, unless many scintigrams are performed, are disadvantages.
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
January 1990,
European journal of nuclear medicine,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
January 1991,
European journal of nuclear medicine,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
January 1990,
Scandinavian journal of gastroenterology. Supplement,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
January 1989,
European journal of nuclear medicine,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
July 1982,
British medical journal (Clinical research ed.),
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
December 1992,
Nuclear medicine communications,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
August 2000,
The American journal of gastroenterology,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
February 1983,
Gastroenterology,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
June 1990,
Diseases of the colon and rectum,
K J Fotherby, and
E P Wraight, and
H Garforth, and
J O Hunter
January 1996,
Gut,
